TY  - JOUR
AU  - Puig, Noemi
AU  - Paiva, Bruno
AU  - Lasa, Marta
AU  - Burgos, Leire
AU  - Perez, Jose J
AU  - Merino, Juana
AU  - Moreno, Cristina
AU  - Vidriales, Maria-Belen
AU  - Toboso, Dolores Gómez
AU  - Cedena, Maria-Teresa
AU  - Ocio, Enrique M
AU  - Lecumberri, Ramon
AU  - García de Coca, Alfonso
AU  - Labrador, Jorge
AU  - Gonzalez, Maria-Esther
AU  - Palomera, Luis
AU  - Gironella, Mercedes
AU  - Cabañas, Valentin
AU  - Casanova, Maria
AU  - Oriol, Albert
AU  - Krsnik, Isabel
AU  - Pérez-Montaña, Albert
AU  - de la Rubia, Javier
AU  - de la Puerta, Jose-Enrique
AU  - de Arriba, Felipe
AU  - Prosper, Felipe
AU  - Martinez-Lopez, Joaquin
AU  - Lecrevisse, Quentin
AU  - Verde, Javier
AU  - Mateos, Maria-Victoria
AU  - Lahuerta, Juan-Jose
AU  - Orfao, Alberto
AU  - San Miguel, Jesús F
PY  - 2018
DO  - 10.1038/s41375-018-0308-5
UR  - https://hdl.handle.net/10668/26671
T2  - Leukemia
AB  - Early diagnosis and risk stratification are key to improve outcomes in light-chain (AL) amyloidosis. Here we used multidimensional-flow-cytometry (MFC) to characterize bone marrow (BM) plasma cells (PCs) from a series of 166 patients including...
LA  - en
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers
KW  - Bone Marrow
KW  - Clonal Evolution
KW  - Female
KW  - Flow Cytometry
KW  - Humans
KW  - Immunoglobulin Isotypes
KW  - Immunoglobulin Light-chain Amyloidosis
KW  - Immunophenotyping
KW  - Male
KW  - Mass Screening
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Risk Assessment
TI  - Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis.
TY  - research article
VL  - 33
ER  -